Identification of FKBP11 as a biomarker for hepatocellular carcinoma

Anticancer Research

Volumn 33, Issue 6, 2013, Pages 2763-2770

  Lin, I Yin ^a   Yen, Chia Hung ^b,c   Liao, Yi Jen ^d   Lin, Sey En ^e,f   Ma, Hon Ping ^g   Chan, Yu Jiun ^h   Chen, Yi Ming A ^c,i  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Graduate Institute and School of Pharmacy   (Taiwan)

^c Center for Infectious Disease and Cancer Research   (Taiwan)

^d School of Medical Laboratory Science and Biotechnology   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f School of Medicine   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^h TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

ⁱ KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

FK506 binding protein; FKBP11; FKBP19; GNMT; HCC

Indexed keywords

FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 11; UNCLASSIFIED DRUG; FKBP11 PROTEIN, HUMAN; GLYCINE METHYLTRANSFERASE; GNMT PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER;

ADULT; ARTICLE; FEMALE; HEMANGIOMA; HEPATITIS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS HEPATITIS; VIRUS INFECTION; ANIMAL; FKBP11; FKBP19; GENE EXPRESSION; GENETICS; GNMT; HCC; LIVER; LIVER TUMOR; METABOLISM; MOUSE; MOUSE MUTANT; TUMOR SUPPRESSOR GENE;

FK506 BINDING PROTEIN; FKBP11; FKBP19; GNMT; HCC;

ANIMALS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; GLYCINE N-METHYLTRANSFERASE; HEMANGIOMA; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, KNOCKOUT; RNA, MESSENGER; TACROLIMUS BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84881331173     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
2. Finn RS: Development of molecularly targeted therapies in hepatocellular carcinoma: Where do we go now? Clin Cancer Res 16: 390-397, 2010.
3. Roxburgh P and Evans TR: Systemic therapy of hepatocellular carcinoma: Are we making progress? Adv Ther 25: 1089-1104, 2008.
4. Poon RT, Fan ST, Tsang FH and Wong J: Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective. Ann Surg 235: 466-486, 2002.
5. Llovet JM and Bruix J: Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48: 1312-1327, 2008.
6. Liao YJ, Liu SP, Lee CM, Yen CH, Chuang PC, Chen CY, Tsai TF, Huang SF, Lee YH and Chen YM: Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility. Int J Cancer 124: 816-826, 2009.
7. Martinez-Chantar ML, Vazquez-Chantada M, Ariz U, Martinez N, Varela M, Luka Z, Capdevila A, Rodriguez J, Aransay AM, Matthiesen R, Yang H, Calvisi DF, Esteller M, Fraga M, Lu SC, Wagner C and Mato JM: Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 47: 1191-1199, 2008.
8. Cook RJ and Wagner C: Glycine N-methyltransferase is a folate binding protein of rat liver cytosol. Proc Natl Acad Sci USA 81: 3631-3634, 1984.
9. Ogawa H and Fujioka M: Purification and properties of glycine N-methyltransferase from rat liver. J Biol Chem 257: 3447-3452, 1982.
10. Bhat R and Bresnick E: Glycine N-methyltransferase is an example of functional diversity. Role as a polycyclic aromatic hydrocarbon-binding receptor. J Biol Chem 272: 21221-21226, 1997.
11. Chen SY, Lin JR, Darbha R, Lin P, Liu TY and Chen YM: Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene- detoxification pathway. Cancer Res 64: 3617-3623, 2004.
12. Yen CH, Hung JH, Ueng YF, Liu SP, Chen SY, Liu HH, Chou TY, Tsai TF, Darbha R, Hsieh LL and Chen YM: Glycine Nmethyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect. Toxicol Appl Pharmacol 235: 296-304, 2009.
13. Chen YM, Chen LY, Wong FH, Lee CM, Chang TJ and Yang-Feng TL: Genomic structure, expression, and chromosomal localization of the human glycine N-methyltransferase gene. Genomics 66: 43-47, 2000.
14. Liu HH, Chen KH, Shih YP, Lui WY, Wong FH and Chen YM: Characterization of reduced expression of glycine Nmethyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies. J Biomed Sci 10: 87-97, 2003.
15. Rulten SL, Kinloch RA, Tateossian H, Robinson C, Gettins L and Kay JE: The human FK506-binding proteins: characterization of human FKBP19. Mamm Genome 17: 322-331, 2006.
16. Sabatini DM: mTOR and cancer: Insights into a complex relationship. Nat Rev Cancer 6: 729-734, 2006.
17. Patterson CE, Gao J, Rooney AP and Davis EC: Genomic organization of mouse and human 65 kDa FK506-binding protein genes and evolution of the FKBP multigene family. Genomics 79: 881-889, 2002.
18. Zhang K, Wang S, Malhotra J, Hassler JR, Back SH, Wang G, Chang L, Xu W, Miao H, Leonardi R, Chen YE, Jackowski S and Kaufman RJ: The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis. EMBO J 30: 1357-1375, 2011.
19. Liu SP, Li YS, Chen YJ, Chiang EP, Li AF, Lee YH, Tsai TF, Hsiao M, Huang SF and Chen YM: Glycine Nmethyltransferase-/-mice develop chronic hepatitis and glycogen storage disease in the liver. Hepatology 46: 1413-1425, 2007.
20. Lee CM, Chen SY, Lee YC, Huang CY and Chen YM: Benzo[a]pyrene and glycine N-methyltransferse interactions: gene expression profiles of the liver detoxification pathway. Toxicol Appl Pharmacol 214: 126-135, 2006.
21. Yen CH, Lin YT, Chen HL, Chen SY and Chen YM: The multifunctional roles of GNMT in toxicology and cancer. Toxicol Appl Pharmacol 266: 67-75, 2013.
22. Yen CH, Lu YC, Li CH, Lee CM, Chen CY, Cheng MY, Huang SF, Chen KF, Cheng AL, Liao LY, Lee YH and Chen YM: Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma. Mol Med 18: 286-296, 2012.
23. Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, Biankin AV and Biden TJ: Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50: 752-763, 2007.
24. Ji C and Kaplowitz N: ER stress: Can the liver cope? J Hepatol 45: 321-333, 2006.
25. Wu J and Kaufman RJ: From acute ER stress to physiological roles of the unfolded protein response. Cell Death Differ 13: 374-384, 2006.
26. Wang HC, Wu HC, Chen CF, Fausto N, Lei HY and Su IJ: Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol 163: 2441-2449, 2003.
27. Shuda M, Kondoh N, Imazeki N, Tanaka K, Okada T, Mori K, Hada A, Arai M, Wakatsuki T, Matsubara O, Yamamoto N and Yamamoto M: Activation of the ATF6, XBP1 and GRP78 genes in human hepatocellular carcinoma: A possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 38: 605-614, 2003.